Launch of NIPT tests in Japan, representing more than 250,000 high risk pregnancies, has created an unprecedented demand for these tests, says RNCOS.
Online PR News – 12-May-2015 – NOIDA/UP – According to a new research report by RNCOS entitled, “Asia Pacific NIPT Market Outlook 2018”, Japan represents a market with incredible possibilities for growth. In an otherwise weakening market of medical devices, NIPT has emerged as a niche sector with immense growth forecasts. It is estimated that the market is expected to grow at a prolific CAGR of around 42% during 2013-2018.
In Japan, around 60% of pregnant women have a greater than 1:1,000 chance of having a baby with Down’s syndrome. According to RNCOS estimates, 628,866 women aged above 30 gave birth in 2013 and this figure is not expected to change much by 2018. These women represent the potential customer base which is likely to buy a NIPT test to assure themselves about the normalcy of the genetic status of their fetus. Of these, around 265,000 women fall under the high risk group of 35 years and above. These women represent the consumer base that is most likely to buy a NIPT test during pregnancy.
According to the guidelines released by Japan Society of Obstetrics and Gynecology, NIPT testing will be available primarily to pregnant women of advanced age, generally considered 35 or older, and those found at risk of carrying babies with abnormalities in earlier exams, including sonograms. In such a context, therefore, the figure of more than 265,000 women aged above 35 years represents the potential customer base for NIPT tests in Japan.
The report provides an in-depth analysis of the current market scenario and expected outlook by 2018. Regions covered in the report include Australia, India, Japan and China. Each region’s data coverage include the number of births, analysis of the potential patient population that will form the customer base for NIPT tests, potential market, market size, forecasts, competitive landscape and regulatory scenario. The report is an outcome of the in-depth analysis of insights generated through interviews with industry leaders and regulatory experts. All the data has been collated through various sources to present the most authentic and impartial picture. It is a must buy for any player that wishes to enter the highly lucrative APAC NIPT market.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM714.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.